Treatment of unexplained chronic cough: CHEST guideline and expert panel report
P Gibson, G Wang, L McGarvey, AE Vertigan… - Chest, 2016 - Elsevier
Background Unexplained chronic cough (UCC) causes significant impairments in quality of
life. Effective assessment and treatment approaches are needed for UCC. Methods This …
life. Effective assessment and treatment approaches are needed for UCC. Methods This …
Management of chronic refractory cough
PG Gibson, AE Vertigan - Bmj, 2015 - bmj.com
Chronic refractory cough (CRC) is defined as a cough that persists despite guideline based
treatment. It is seen in 20-46% of patients presenting to specialist cough clinics and it has a …
treatment. It is seen in 20-46% of patients presenting to specialist cough clinics and it has a …
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children
AH Morice, E Millqvist, K Bieksiene… - European …, 2020 - Eur Respiratory Soc
These guidelines incorporate the recent advances in chronic cough pathophysiology,
diagnosis and treatment. The concept of cough hypersensitivity has allowed an umbrella …
diagnosis and treatment. The concept of cough hypersensitivity has allowed an umbrella …
Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report
Background We performed systematic reviews using the population, intervention,
comparison, outcome (PICO) format to answer the following key clinical question: Are the …
comparison, outcome (PICO) format to answer the following key clinical question: Are the …
Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report
Background We updated the 2006 ACCP clinical practice guidelines for management of
reflux-cough syndrome. Methods Two population, intervention, comparison, outcome (PICO) …
reflux-cough syndrome. Methods Two population, intervention, comparison, outcome (PICO) …
Efficacy and tolerability of gefapixant for treatment of refractory or unexplained chronic cough: a systematic review and dose-response meta-analysis
Importance Gefapixant represents an emerging therapy for patients with refractory or
unexplained chronic cough. Objective To evaluate the efficacy and tolerability of gefapixant …
unexplained chronic cough. Objective To evaluate the efficacy and tolerability of gefapixant …
What is chronic cough? Terminology
L McGarvey, PG Gibson - The Journal of Allergy and Clinical Immunology …, 2019 - Elsevier
Terminology used to define clinical cough is based on features such as duration, underlying
causes, and associated characteristics such as whether the cough is “dry” or “productive.” …
causes, and associated characteristics such as whether the cough is “dry” or “productive.” …
Cough hypersensitivity syndrome: why its use is inappropriate in children
AB Chang, RS Irwin, HE O'Farrell… - Journal of Clinical …, 2023 - mdpi.com
In children and adults, chronic cough is a common symptom presenting to health
professionals worldwide. It is internationally accepted that children with chronic cough …
professionals worldwide. It is internationally accepted that children with chronic cough …
Characterization of patients with refractory or unexplained chronic cough participating in a phase 2 clinical trial of the P2X3-receptor antagonist gefapixant
Purpose This analysis assesses clinical characteristics of patients with refractory chronic
cough (RCC) or unexplained chronic cough (UCC) enrolled in a phase 2 study to better …
cough (RCC) or unexplained chronic cough (UCC) enrolled in a phase 2 study to better …
Change in psychological, physiological, and situational factors in adults after treatment of chronic cough
CL French, SL Crawford, C Bova, RS Irwin - Chest, 2017 - Elsevier
Background We hypothesized that addressing anxiety and depressive mood disorders will
improve chronic cough severity and cough quality of life (CQOL). Methods Major tenets of …
improve chronic cough severity and cough quality of life (CQOL). Methods Major tenets of …